Hepatitis C virus (HCV) is commonly spread through blood from a person who has been infected through use of shared needles or equipment used to inject drugs. HCV is a liver-infecting virus that causes acute (new and short-lived) and chronic (long-lasting) forms of hepatitis C.
The incidence rates of HCV vary noticeably, registering the highest rate in the North America. In the past few years, the cases of HCV have increased tremendously in the US, European, Asian and African regions. Comprising of two segments - diagnostic and treatment, the HCV market is driven by various factors like growing world population, obesity, increasing number of HCV incidences globally and rise in number of HCV positive drug addicts.
The global market for HCV drugs represents an area of potential opportunity in both developed and developing countries. Due to the effectiveness and advancements in technologies, large number of companies are focused on developing innovative HCV drugs. Further, the companies are forming alliances and agreements to develop effective treatments for HCV. In the long-term, the growth of global HCV drugs market is expected to come more from emerging markets like the Asia-Pacific, Middle East countries, African and Latin America countries as these regions are likely to register maximum number of HCV incidences in years to come due to increase in number of HCV positive drug addicts.
This report titled “Global Hepatitis C Virus (HCV) Market- An Analysis” analyzes the various types, stages and incidences of HCV in different geographies. In the report, the markets for diagnosis and treatment of hepatitis C virus, including overall HCV drugs market, have been analyzed. The report also discusses the various factors that will drive the HCV diagnosis and treatment market. Key HCV market trends and issues have also been discussed. The report also presents the competitive structure of the industry and profiles major players in the HCV drugs market including Roche, Merck Pharmaceutical and Vertex Pharmaceutical.
Further, we have predicted the future growth of the global HCV drugs market by combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings. We employed various significant variables that have an impact on this industry and created regression models with SPSS to determine the future direction of the industry.